Kamalan Jeevaratnam

Dr. Kamalan Jeevaratnam

Head of Department (Pre-clinical Sciences), Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7AL, Surrey, UK
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2021 in Quantum Reports
Verified
Journal Article
Open access
PDF file
YKYoungchan Kim
Youngchan Kim
FBFederico Bertagna
Federico Bertagna
EDEdeline M. D’souza
Edeline M. D’souza
DHDerren Heyes
Derren Heyes
LJLinus O. Johannissen
Linus O. Johannissen
JMJohnjoe Mcfadden
Johnjoe Mcfadden
Understanding the rules of life is one of the most important scientific endeavours and has revolutionised both biology and biotechnology. Remarkable advances in observation techniques allow us to investigate a broad range of complex and dynamic biological processes in which living systems could exploit quantum behaviour to enhance and regulate biological functions. Recent evidence suggests that these non-trivial quantum mechanical effects may play a crucial role in maintaining the non-equilibrium state of biomolecular systems. Quantum biology is the study of such quantum aspects of living systems. In this review, we summarise the latest progress in quantum biology, including the areas of enzyme-catalysed reactions, photosynthesis, spin-dependent reactions, DNA, fluorescent proteins, and ion channels. Many of these results are expected to be fundamental building blocks towards understanding the rules of life.

20 September 2013 in Medical Teacher
Verified
Journal Article
Closed access
APAllan Pau
Allan Pau
KJKamalan Jeevaratnam
Kamalan Jeevaratnam
YCYu Sui Chen
Yu Sui Chen
AFAbdoul Aziz Fall
Abdoul Aziz Fall
CKCharmaine Khoo
Charmaine Khoo
VNVishna Devi Nadarajah
Vishna Devi Nadarajah
The Multiple Mini-Interview (MMI) has been used increasingly for selection of students to health professions programmes. This paper reports on the evidence base for the feasibility, acceptability, reliability and validity of the MMI. CINAHL and MEDLINE STUDY ELIGIBILITY CRITERIA: All studies testing the MMI on applicants to health professions training. Each paper was appraised by two reviewers. Narrative summary findings on feasibility, acceptability, reliability and validity are presented. Of the 64 citations identified, 30 were selected for review. The modal MMI consisted of 10 stations, each lasting eight minutes and assessed by one interviewer. The MMI was feasible, i.e. did not require more examiners, did not cost more, and interviews were completed over a short period of time. It was acceptable, i.e. fair, transparent, free from gender, cultural and socio-economic bias, and did not favour applicants with previous coaching. Its reliability was reported to be moderate to high, with Cronbach's alpha = 0.69-0.98 and G = 0.55-0.72. MMI scores did not correlate to traditional admission tools scores, were not associated with pre-entry academic qualifications, were the best predictor for OSCE performance and statistically predictive of subsequent performance at medical council examinations. The MMI is reliable, acceptable and feasible. The evidence base for its validity against future medical council exams is growing with reports from longitudinal investigations. However, further research is needed for its acceptability in different cultural context and validity against future clinical behaviours.

10 June 2016 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
NLNathanael Y S Lee
Nathanael Y S Lee
WKWilliam K S Khoo
William K S Khoo
MAMohammad Akmal Adnan
Mohammad Akmal Adnan
TMTanes Prasat Mahalingam
Tanes Prasat Mahalingam
AFAnne R Fernandez
Anne R Fernandez
KJKamalan Jeevaratnam
Kamalan Jeevaratnam

25 September 2017 in Journal of Cardiovascular Pharmacology and Therapeutics
Verified
Journal Article
Open access
KJKamalan Jeevaratnam
Kamalan Jeevaratnam
KCKaran R. Chadda
Karan R. Chadda
CHChristopher L.-H. Huang
Christopher L.-H. Huang
ACA. John Camm
A. John Camm
The development of novel drugs specifically directed at the ion channels underlying particular features of cardiac action potential (AP) initiation, recovery, and refractoriness would contribute to an optimized approach to antiarrhythmic therapy that minimizes potential cardiac and extracardiac toxicity. Of these, K+channels contribute numerous and diverse currents with specific actions on different phases in the time course of AP repolarization. These features and their site-specific distribution make particular K+channel types attractive therapeutic targets for the development of pharmacological agents attempting antiarrhythmic therapy in conditions such as atrial fibrillation. However, progress in the development of such temporally and spatially selective antiarrhythmic drugs against particular ion channels has been relatively limited, particularly in view of our incomplete understanding of the complex physiological roles and interactions of the various ionic currents. This review summarizes the physiological properties of the main cardiac potassium channels and the way in which they modulate cardiac electrical activity and then critiques a number of available potential antiarrhythmic drugs directed at them.

9 March 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
KCKaran R. Chadda
Karan R. Chadda
EBEllen E. Blakey
Ellen E. Blakey
CHChristopher L. -H. Huang
Christopher L. -H. Huang
KJKamalan Jeevaratnam
Kamalan Jeevaratnam
While the increased arrhythmic tendency during acute COVID-19 infection is recognised, the long-term cardiac electrophysiological complications are less well known. There are a high number of patients reporting ongoing symptoms post-infection, termed long COVID. A recent hypothesis is that long COVID symptoms could be attributed to dysautonomia, defined as malfunction of the autonomic nervous system (ANS). The most prevalent cardiovascular dysautonomia amongst young people is postural orthostatic tachycardia syndrome (POTS). Numerous reports have described the development of POTS as part of long COVID. Possible underlying mechanisms, although not mutually exclusive or exhaustive, include hypovolaemia, neurotropism, inflammation and autoimmunity. Treatment options for POTS and other long COVID symptoms are currently limited. Future research studies should aim to elucidate the underlying mechanisms of dysautonomia to enable the development of targeted therapies. Furthermore, it is important to educate healthcare professionals to recognise complications and conditions arising from COVID-19, such as POTS, to allow prompt diagnosis and access to early treatment.

1 December 2018 in Ageing Research Reviews
Verified
Journal Article
Closed access
KCKaran R. Chadda
Karan R. Chadda
OAOlujimi A. Ajijola
Olujimi A. Ajijola
MVMarmar Vaseghi
Marmar Vaseghi
KSKalyanam Shivkumar
Kalyanam Shivkumar
CHChristopher Huang
Christopher Huang
KJKamalan Jeevaratnam
Kamalan Jeevaratnam